The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Trachtenberg, Alexander ^a   Pushkarsky, Tatiana ^a   Heine, Shannon ^a   Constant, Stephanie ^a,b   Brichacek, Beda ^a,c   Bukrinsky, Michael ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053643392     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-396     Document Type: Article

References (29)

1. Structure, function, and inhibition of chemokines. Fernandez EJ, Lolis E, Annu Rev Pharmacol Toxicol 2002 42 469 499 10.1146/annurev.pharmtox.42.091901. 115838 11807180 (Pubitemid 34160533)
2. Cyclophilins: unexpected messengers in intercellular communications. Bukrinsky MI, Trends Immunol 2002 23 323 325 10.1016/S1471-4906(02)02237-8 12103338 (Pubitemid 34717897)
3. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, et al. J Biol Chem 2002 277 22959 22965 10.1074/jbc.M201593200 11943775 (Pubitemid 34967280)
4. Extracellular cyclophilins contribute to the regulation of inflammatory responses. Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, et al. J Immunol 2005 175 517 522 15972687 (Pubitemid 40884357)
5. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. Gwinn WM, Damsker J, Falahati R, Okwumabua I, Kelly-Welsh A, Keegan A, et al. J Immunol 2006 177 4870 4879 16982929 (Pubitemid 44469823)
6. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. Damsker JM, Bukrinsky MI, Constant SL, J Leukoc Biol 2007 82 613 618 10.1189/jlb.0506317 17540735 (Pubitemid 47367153)
7. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Sherry B, Yarlett N, Strupp A, Cerami A, Proc Natl Acad Sci USA 1992 89 3511 3515 10.1073/pnas.89.8.3511 1565646
8. Leukocyte chemotactic activity of cyclophilin. Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR, J Biol Chem 1992 267 11968 11971 1601866
9. CD147 is a signaling receptor for cyclophilin B. Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, et al. Biochem Biophys Res Commun 2001 288 786 788 10.1006/bbrc.2001.5847 11688976 (Pubitemid 33140950)
10. CD147 stimulates HIV-1 infection in a signal-independent fashion. Pushkarsky T, Yurchenko V, Laborico A, Bukrinsky M, Biochem Biophys Res Commun 2007 363 495 499 10.1016/j.bbrc.2007.08.192 17888876 (Pubitemid 47513657)
11. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. Berditchevski F, Chang S, Bodorova J, Hemler ME, J Biol Chem 1997 272 29174 29180 10.1074/jbc.272.46.29174 9360995 (Pubitemid 27498208)
12. The functional interactions between CD98, {beta}1-integrins, and CD147 in the induction of U937 homotypic aggregation. Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, et al. Blood 2001 98 374 382 10.1182/blood.V98.2.374 11435306
13. Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases. Melchior A, Denys A, Deligny A, Mazurier J, Allain F, Exp Cell Res 2008 314 616 628 10.1016/j.yexcr.2007.11.007 18054915
14. Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. Pakula R, Melchior A, Denys A, Vanpouille C, Mazurier J, Allain F, Glycobiology 2007 17 492 503 17267519 (Pubitemid 47049937)
15. Extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) as a novel regulator of myogenic cell differentiation. Attia M, Huet E, Delbe J, Ledoux D, Menashi S, Martelly I, J Cell Physiol 2011 226 141 149 10.1002/jcp.22315 20648565
16. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Hao JL, Cozzi PJ, Khatri A, Power CA, Li Y, Curr Cancer Drug Targets 2010 10 287 306 10.2174/156800910791190193 20370680
17. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. Cancer Res 1995 55 434 439 7812975
18. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. Kimpton J, Emerman M, J Virol 1992 66 2232 2239 1548759
19. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. Ganor Y, Teichberg VI, Levite M, J Immunol 2007 178 683 692 17202328 (Pubitemid 46095140)
20. A 40-kDa myelin basic protein kinase, distinct from erk1 and erk2, is activated in mitotic HeLa cells. Heider H, Hug C, Lucocq JM, Eur J Biochem 1994 219 513 520 10.1111/j.1432-1033.1994.tb19966.x 8307019 (Pubitemid 24053669)
21. Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain. Yoshida S, Shibata M, Yamamoto S, Hagihara M, Asai N, Takahashi M, et al. Eur J Biochem 2000 267 4372 4380 10880960 (Pubitemid 30461069)
22. Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis. Hamatake M, Aoki T, Futahashi Y, Urano E, Yamamoto N, Komano J, Cancer Sci 2009 100 95 102 10.1111/j.1349-7006.2008.00997.x 19018754
23. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. Handel TM, Johnson Z, Rodrigues DH, Dos Santos AC, Cirillo R, Muzio V, et al. J Leukoc Biol 2008 84 1101 1108 10.1189/jlb.0108061 18662971
24. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Wang J, He L, Combs CA, Roderiquez G, Norcross MA, Mol Cancer Ther 2006 5 2474 2483 10.1158/1535-7163.MCT-05-0261 17041091 (Pubitemid 44650911)
25. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. Schlegel J, Redzic JS, Porter CC, Yurchenko V, Bukrinsky M, Labeikovsky W, et al. J Mol Biol 2009 391 518 535 10.1016/j.jmb.2009.05.080 19500591
26. Cancer-related issues of CD147. Weidle UH, Scheuer W, Eggle D, Klostermann S, Stockinger H, Cancer Genomics Proteomics 2010 7 157 169 20551248
27. Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. Yurchenko V, Pushkarsky T, Li JH, Dai WW, Sherry B, Bukrinsky M, J Biol Chem 2005 280 17013 17019 10.1074/jbc.M412851200 15671024 (Pubitemid 41389163)
28. Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, et al. J Biol Chem 2005 280 27866 27871 10.1074/jbc.M503770200 15946952 (Pubitemid 41076903)
29. Identification of a nuclear-specific cyclophilin which interacts with the proteinase inhibitor eglin c. Wang BB, Hayenga KJ, Payan DG, Fisher JM, Biochem J 1996 314 Pt 1 313 319 8660300 (Pubitemid 26063864)